Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
BMJ Open|February 2, 2022
Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER databaseNing Xie, Xiaobo Hu, Yu Tang, et al.
BMC Cancer|July 30, 2024
The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional studyZhe-Yu Hu, Binliang Liu, Ning Xie, et al.
Frontiers in Oncology|March 14, 2022
Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in <i>TP53</i>-Aberrant Triple-Negative Breast CancerZhe-Yu Hu, Chanjuan Zheng, Jianbo Yang, et al.
Cancer Innovation|October 28, 2024
Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancerBinliang Liu, Zhe-Yu Hu, Ning Xie, et al.
Therapeutic Advances in Medical Oncology|June 6, 2020
<i>FGFR</i> aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patientsNing Xie, Can Tian, Hui Wu, et al.
Breast (Edinburgh, Scotland)|July 24, 2025
BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label studyZhe-Yu Hu, Kegang Jiang, Can Tian, et al.
Frontiers in Oncology|March 21, 2022
Real-World First-Line Treatment Patterns and Outcomes in Hormone Receptor-Positive Advanced Breast Cancer Patients: A Multicenter, Retrospective Study in ChinaZhanhong Chen, Quchang Ouyang, Yongsheng Wang, et al.
Breast (Edinburgh, Scotland)|November 9, 2023
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibodyBinliang Liu, Ning Xie, Can Tian, et al.
Ebiomedicine|May 30, 2018
Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline ResistanceZhe-Yu Hu, Ning Xie, Can Tian, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2025
Hereditary Angioedema (HAE) in China: Advancing Awareness, Access, Advocacy and Alliances From the Greater Bay Area to the Global HAE CommunityPhilip H Li, Jin-Xian Huang, Can-Tian Wang, et al.
Pageof 5